back to US directory
us clinical guidance

Diabetes before, during and after pregnancy

ADA 2026 preconception optimization, pregnancy glucose monitoring, insulin-first pharmacotherapy, technology and postpartum follow-up.

JurisdictionUnited States
Source check2026-08-20
Clinical reviewiatroX editorial team · Clinical editorial review · reviewed 2026-08-20 · due 2027-08-20
AudienceUnited States diabetes, obstetric and primary-care healthcare professionals
This is an iatroX educational summary of named United States sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Use the named authority, current FDA labeling, applicable state law, payer rules and local protocol where relevant.

Scope of this summary

People with type 1 or type 2 diabetes entering pregnancy and those diagnosed with gestational diabetes. Detailed diagnostic glucose-load protocols, insulin dose algorithms, obstetric surveillance and neonatal management require the full ADA and local maternal-fetal medicine pathways.
sources for this section:ADA 2026 §15

The Bottom Line

  • Integrate pregnancy planning into diabetes care from puberty and use effective contraception until medicines, complications and glycemia are optimized for a desired pregnancy.
  • Aim for preconception A1C below 6.5% when achievable without excessive hypoglycemia, while reviewing retinopathy, kidney disease, hypertension, thyroid disease and medication safety.
  • During pregnancy, monitor fasting and postprandial glucose; ADA 2026 uses targets below 95 mg/dL fasting, below 140 mg/dL at one hour or below 120 mg/dL at two hours.
  • Insulin is required for type 1 diabetes and is the preferred medication for gestational and type 2 diabetes in pregnancy when pharmacotherapy is needed.
  • Recommend continuous glucose monitoring in type 1 diabetes pregnancy and use pregnancy-specific automated delivery when available, with an experienced team and backup plan.
sources for this section:ADA 2026 §15

Practical clinical workflow

1
Before conception or at first presentation, establish diabetes type, duration, A1C, hypoglycemia, ketones, kidney and retinal status, blood pressure, medicines, nutrition, social barriers and pregnancy dating.
2
Create an individualized meal, activity, glucose and ketone-monitoring plan and arrange rapid access for insulin titration as requirements change across gestation.
3
Coordinate endocrinology, maternal-fetal medicine, diabetes education, nutrition and psychosocial care; review fetal assessment and aspirin eligibility under the obstetric pathway.
4
Prepare delivery and postpartum insulin reduction, lactation, contraception and hypoglycemia plans before birth rather than reacting after placental delivery.
5
After gestational diabetes, perform the source-recommended postpartum glucose test and continue lifelong screening at least every three years, addressing cardiovascular and future-pregnancy risk.
sources for this section:ADA 2026 §15

Safety boundaries and escalation

  • Vomiting, ketones, rising glucose, dehydration or illness can represent diabetic ketoacidosis at lower glucose levels during pregnancy and requires immediate specialist or emergency assessment.
  • Severe hypoglycemia, recurrent nocturnal lows or impaired awareness requires urgent regimen and technology review; glycemic targets should not be pursued at the cost of dangerous hypoglycemia.
  • Do not continue a glucose-lowering, antihypertensive or lipid medicine into conception without pregnancy review; GLP-1 and dual GIP/GLP-1 therapies need source- and product-specific discontinuation planning.
  • Retinopathy can progress with pregnancy and rapid glycemic improvement, so eye assessment and coordinated follow-up must not be omitted.
sources for this section:ADA 2026 §15

Localization

The ADA Standards are updated annually; this summary uses the 2026 pregnancy chapter and must be rechecked when a focused update or 2027 Standards appear.
sources for this section:ADA 2026 §15

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. American Diabetes Association Professional Practice Committee for Diabetes15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026DOI 10.2337/dc26-S015 · published 2025-12-08 · accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page’s provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what—if anything—you may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.